164 related articles for article (PubMed ID: 38579171)
21. Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 β-cell line.
Krautkramer KA; Linnemann AK; Fontaine DA; Whillock AL; Harris TW; Schleis GJ; Truchan NA; Marty-Santos L; Lavine JA; Cleaver O; Kimple ME; Davis DB
Am J Physiol Endocrinol Metab; 2013 Sep; 305(5):E600-10. PubMed ID: 23860123
[TBL] [Abstract][Full Text] [Related]
22. Identification of
Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
[No Abstract] [Full Text] [Related]
23. Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.
Lu W; Xu Y; Xu J; Wang Z; Ye G
Cancer Med; 2018 Aug; 7(8):3935-3944. PubMed ID: 29923329
[TBL] [Abstract][Full Text] [Related]
24. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
Jendrzejewski J; He H; Radomska HS; Li W; Tomsic J; Liyanarachchi S; Davuluri RV; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2012 May; 109(22):8646-51. PubMed ID: 22586128
[TBL] [Abstract][Full Text] [Related]
25. Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathways.
Adewuyi EO; Mehta D; ; ; Nyholt DR
Hum Reprod; 2022 Jan; 37(2):366-383. PubMed ID: 35472084
[TBL] [Abstract][Full Text] [Related]
26. Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
Gugnoni M; Manicardi V; Torricelli F; Sauta E; Bellazzi R; Manzotti G; Vitale E; de Biase D; Piana S; Ciarrocchi A
Thyroid; 2021 Feb; 31(2):247-263. PubMed ID: 32495722
[No Abstract] [Full Text] [Related]
27. Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8
Ma X; Wang Q; Sun C; Agarwal I; Wu H; Chen J; Zhao C; Qi G; Teng Q; Yuan C; Yan S; Peng J; Li R; Song K; Zhang Q; Kong B
Cell Rep; 2023 Aug; 42(8):112944. PubMed ID: 37566545
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
Geraldo MV; Nakaya HI; Kimura ET
Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
[TBL] [Abstract][Full Text] [Related]
29. Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
Corrado A; Aceto R; Silvestri R; Dell'Anno I; Ricci B; Miglietta S; Romei C; Giovannoni R; Poliseno L; Evangelista M; Vitiello M; Cipollini M; Garritano S; Giusti L; Zallocco L; Elisei R; Landi S; Gemignani F
Thyroid; 2021 Jul; 31(7):1056-1066. PubMed ID: 33308024
[No Abstract] [Full Text] [Related]
30. A 4 Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
Li CW; Shi X; Ma B; Wang YL; Lu ZW; Liao T; Wang Y; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3208-e3220. PubMed ID: 33656532
[TBL] [Abstract][Full Text] [Related]
31. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
Landa I; Ruiz-Llorente S; Montero-Conde C; Inglada-Pérez L; Schiavi F; Leskelä S; Pita G; Milne R; Maravall J; Ramos I; Andía V; Rodríguez-Poyo P; Jara-Albarrán A; Meoro A; del Peso C; Arribas L; Iglesias P; Caballero J; Serrano J; Picó A; Pomares F; Giménez G; López-Mondéjar P; Castello R; Merante-Boschin I; Pelizzo MR; Mauricio D; Opocher G; Rodríguez-Antona C; González-Neira A; Matías-Guiu X; Santisteban P; Robledo M
PLoS Genet; 2009 Sep; 5(9):e1000637. PubMed ID: 19730683
[TBL] [Abstract][Full Text] [Related]
32. A Novel Mouse Model of Autoimmune Thyroiditis Induced by Immunization with Adenovirus Containing Full-Length Thyroglobulin cDNA: Implications to Genetic Studies of Thyroid Autoimmunity.
Faustino LC; Li CW; Stefan-Lifshitz M; Kim K; Clarke OB; Tomer Y
Thyroid; 2020 Sep; 30(9):1338-1345. PubMed ID: 32228171
[No Abstract] [Full Text] [Related]
33. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
34. TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Zhou ZH; Chen G; Deng C; Tang JM; Xie L; Zhou HY; Ye X; Zhang DK; Shi RQ; Tian D; Qiao GB; Ben XS
Cell Biol Int; 2019 Dec; 43(12):1416-1424. PubMed ID: 31141247
[TBL] [Abstract][Full Text] [Related]
35. Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.
Jung SN; Kang YE; Lee GH; Liu L; Oh C; Jin YL; Lim MA; Lee K; Oh T; Won HR; Chang JW; Koo BS
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32474599
[TBL] [Abstract][Full Text] [Related]
36. TCF19 aggravates the malignant progression of colorectal cancer by negatively regulating WWC1.
Du WB; Huang Z; Luo L; Tong SP; Li HQ; Li X; Tong JH; Yao YL; Zhang WB; Meng Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):655-663. PubMed ID: 32016966
[TBL] [Abstract][Full Text] [Related]
37. Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer.
Imam S; Dar P; Paparodis R; Almotah K; Al-Khudhair A; Hasan SA; Salim N; Jaume JC
J Immunother Cancer; 2019 Jan; 7(1):3. PubMed ID: 30616690
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide association analysis suggests novel loci for Hashimoto's thyroiditis.
Brčić L; Barić A; Gračan S; Brekalo M; Kaličanin D; Gunjača I; Torlak Lovrić V; Tokić S; Radman M; Škrabić V; Miljković A; Kolčić I; Štefanić M; Glavaš-Obrovac L; Lessel D; Polašek O; Zemunik T; Barbalić M; Punda A; Boraska Perica V
J Endocrinol Invest; 2019 May; 42(5):567-576. PubMed ID: 30284222
[TBL] [Abstract][Full Text] [Related]
39. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
[TBL] [Abstract][Full Text] [Related]
40. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
